Changes in G-protein activity mediated through the stimulation of dopamine and GABA(B) receptors in the mesolimbic dopaminergic system of morphine-sensitized mice.
D000818:Animals; D001418:Baclofen / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D018755:GABA Agonists / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000187:drug effects*; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology*; D008032:Limbic System / Q000187:drug effects*; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology*; D016548:Prosencephalon / Q000033:anatomy & histology / Q000187:drug effects*; D011954:Receptors, Dopamine / Q000187:drug effects*; D018080:Receptors, GABA-B / Q000187:drug effects*
D018492:Dopamine Antagonists; D018755:GABA Agonists; D009294:Narcotics; D011954:Receptors, Dopamine; D018080:Receptors, GABA-B; D009020:Morphine; D019204:GTP-Binding Proteins; D001418:Baclofen; D006220:Haloperidol